[Drug-induced phospholipid storage disease].
Identifieur interne : 001066 ( Ncbi/Merge ); précédent : 001065; suivant : 001067[Drug-induced phospholipid storage disease].
Auteurs : H. Lüllmann ; R. Lüllmann-Rauch ; O. WassermannSource :
- Deutsche medizinische Wochenschrift (1946) [ 0012-0472 ] ; 1973.
Descripteurs français
- KwdFr :
- Amitriptyline (effets indésirables), Animaux, Anorexigènes (effets indésirables), Anticholestérolémiants (effets indésirables), Cardiomyopathies (), Chimie, Chloroquine (effets indésirables), Chlorphentermine (effets indésirables), Femelle, Fenfluramine (effets indésirables), Humains, Interactions médicamenteuses, Iprindole (effets indésirables), Lipidoses (), Lysosomes (), Maladies de la thyroïde (), Maladies des surrénales (), Maladies pulmonaires (), Maladies testiculaires (), Mâle, Phospholipides (biosynthèse), Phospholipides (métabolisme), Phénomènes chimiques, Pipérazines (effets indésirables), Poids du corps, Rats, Triparanol (effets indésirables).
- MESH :
- biosynthèse : Phospholipides.
- effets indésirables : Amitriptyline, Anorexigènes, Anticholestérolémiants, Chloroquine, Chlorphentermine, Fenfluramine, Iprindole, Pipérazines, Triparanol.
- métabolisme : Phospholipides.
- Animaux, Cardiomyopathies, Chimie, Femelle, Humains, Interactions médicamenteuses, Lipidoses, Lysosomes, Maladies de la thyroïde, Maladies des surrénales, Maladies pulmonaires, Maladies testiculaires, Mâle, Phénomènes chimiques, Poids du corps, Rats.
English descriptors
- KwdEn :
- Adrenal Gland Diseases (chemically induced), Amitriptyline (adverse effects), Animals, Anticholesteremic Agents (adverse effects), Appetite Depressants (adverse effects), Body Weight, Cardiomyopathies (chemically induced), Chemical Phenomena, Chemistry, Chloroquine (adverse effects), Chlorphentermine (adverse effects), Drug Interactions, Female, Fenfluramine (adverse effects), Humans, Iprindole (adverse effects), Lipidoses (chemically induced), Lung Diseases (chemically induced), Lysosomes (drug effects), Male, Phospholipids (biosynthesis), Phospholipids (metabolism), Piperazines (adverse effects), Rats, Testicular Diseases (chemically induced), Thyroid Diseases (chemically induced), Triparanol (adverse effects).
- MESH :
- chemical , adverse effects : Amitriptyline, Anticholesteremic Agents, Appetite Depressants, Chloroquine, Chlorphentermine, Fenfluramine, Iprindole, Piperazines, Triparanol.
- chemical , biosynthesis : Phospholipids.
- chemically induced : Adrenal Gland Diseases, Cardiomyopathies, Lipidoses, Lung Diseases, Testicular Diseases, Thyroid Diseases.
- drug effects : Lysosomes.
- chemical , metabolism : Phospholipids.
- Animals, Body Weight, Chemical Phenomena, Chemistry, Drug Interactions, Female, Humans, Male, Rats.
DOI: 10.1055/s-0028-1107096
PubMed: 4150413
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000639
- to stream PubMed, to step Curation: 000639
- to stream PubMed, to step Checkpoint: 000607
Links to Exploration step
pubmed:4150413Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Drug-induced phospholipid storage disease].</title><author><name sortKey="Lullmann, H" sort="Lullmann, H" uniqKey="Lullmann H" first="H" last="Lüllmann">H. Lüllmann</name></author><author><name sortKey="Lullmann Rauch, R" sort="Lullmann Rauch, R" uniqKey="Lullmann Rauch R" first="R" last="Lüllmann-Rauch">R. Lüllmann-Rauch</name></author><author><name sortKey="Wassermann, O" sort="Wassermann, O" uniqKey="Wassermann O" first="O" last="Wassermann">O. Wassermann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1973">1973</date><idno type="RBID">pubmed:4150413</idno><idno type="pmid">4150413</idno><idno type="doi">10.1055/s-0028-1107096</idno><idno type="wicri:Area/PubMed/Corpus">000639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000639</idno><idno type="wicri:Area/PubMed/Curation">000639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000639</idno><idno type="wicri:Area/PubMed/Checkpoint">000607</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000607</idno><idno type="wicri:Area/Ncbi/Merge">001066</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Drug-induced phospholipid storage disease].</title><author><name sortKey="Lullmann, H" sort="Lullmann, H" uniqKey="Lullmann H" first="H" last="Lüllmann">H. Lüllmann</name></author><author><name sortKey="Lullmann Rauch, R" sort="Lullmann Rauch, R" uniqKey="Lullmann Rauch R" first="R" last="Lüllmann-Rauch">R. Lüllmann-Rauch</name></author><author><name sortKey="Wassermann, O" sort="Wassermann, O" uniqKey="Wassermann O" first="O" last="Wassermann">O. Wassermann</name></author></analytic><series><title level="j">Deutsche medizinische Wochenschrift (1946)</title><idno type="ISSN">0012-0472</idno><imprint><date when="1973" type="published">1973</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Gland Diseases (chemically induced)</term><term>Amitriptyline (adverse effects)</term><term>Animals</term><term>Anticholesteremic Agents (adverse effects)</term><term>Appetite Depressants (adverse effects)</term><term>Body Weight</term><term>Cardiomyopathies (chemically induced)</term><term>Chemical Phenomena</term><term>Chemistry</term><term>Chloroquine (adverse effects)</term><term>Chlorphentermine (adverse effects)</term><term>Drug Interactions</term><term>Female</term><term>Fenfluramine (adverse effects)</term><term>Humans</term><term>Iprindole (adverse effects)</term><term>Lipidoses (chemically induced)</term><term>Lung Diseases (chemically induced)</term><term>Lysosomes (drug effects)</term><term>Male</term><term>Phospholipids (biosynthesis)</term><term>Phospholipids (metabolism)</term><term>Piperazines (adverse effects)</term><term>Rats</term><term>Testicular Diseases (chemically induced)</term><term>Thyroid Diseases (chemically induced)</term><term>Triparanol (adverse effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Amitriptyline (effets indésirables)</term><term>Animaux</term><term>Anorexigènes (effets indésirables)</term><term>Anticholestérolémiants (effets indésirables)</term><term>Cardiomyopathies ()</term><term>Chimie</term><term>Chloroquine (effets indésirables)</term><term>Chlorphentermine (effets indésirables)</term><term>Femelle</term><term>Fenfluramine (effets indésirables)</term><term>Humains</term><term>Interactions médicamenteuses</term><term>Iprindole (effets indésirables)</term><term>Lipidoses ()</term><term>Lysosomes ()</term><term>Maladies de la thyroïde ()</term><term>Maladies des surrénales ()</term><term>Maladies pulmonaires ()</term><term>Maladies testiculaires ()</term><term>Mâle</term><term>Phospholipides (biosynthèse)</term><term>Phospholipides (métabolisme)</term><term>Phénomènes chimiques</term><term>Pipérazines (effets indésirables)</term><term>Poids du corps</term><term>Rats</term><term>Triparanol (effets indésirables)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Amitriptyline</term><term>Anticholesteremic Agents</term><term>Appetite Depressants</term><term>Chloroquine</term><term>Chlorphentermine</term><term>Fenfluramine</term><term>Iprindole</term><term>Piperazines</term><term>Triparanol</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Phospholipids</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Phospholipides</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Adrenal Gland Diseases</term><term>Cardiomyopathies</term><term>Lipidoses</term><term>Lung Diseases</term><term>Testicular Diseases</term><term>Thyroid Diseases</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Lysosomes</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Amitriptyline</term><term>Anorexigènes</term><term>Anticholestérolémiants</term><term>Chloroquine</term><term>Chlorphentermine</term><term>Fenfluramine</term><term>Iprindole</term><term>Pipérazines</term><term>Triparanol</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Phospholipids</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Phospholipides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Body Weight</term><term>Chemical Phenomena</term><term>Chemistry</term><term>Drug Interactions</term><term>Female</term><term>Humans</term><term>Male</term><term>Rats</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Cardiomyopathies</term><term>Chimie</term><term>Femelle</term><term>Humains</term><term>Interactions médicamenteuses</term><term>Lipidoses</term><term>Lysosomes</term><term>Maladies de la thyroïde</term><term>Maladies des surrénales</term><term>Maladies pulmonaires</term><term>Maladies testiculaires</term><term>Mâle</term><term>Phénomènes chimiques</term><term>Poids du corps</term><term>Rats</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">4150413</PMID><DateCompleted><Year>1974</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0012-0472</ISSN><JournalIssue CitedMedium="Print"><Volume>98</Volume><Issue>35</Issue><PubDate><Year>1973</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Deutsche medizinische Wochenschrift (1946)</Title><ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation></Journal><ArticleTitle>[Drug-induced phospholipid storage disease].</ArticleTitle><Pagination><MedlinePgn>1616 passim</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lüllmann</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lüllmann-Rauch</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Wassermann</LastName><ForeName>O</ForeName><Initials>O</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Arzneimittel-induzierte Phospholipidspeicherkrankheit.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Med Wochenschr</MedlineTA><NlmUniqueID>0006723</NlmUniqueID><ISSNLinking>0012-0472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001067">Appetite Depressants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010743">Phospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>1806D8D52K</RegistryNumber><NameOfSubstance UI="D000639">Amitriptyline</NameOfSubstance></Chemical><Chemical><RegistryNumber>2DS058H2CF</RegistryNumber><NameOfSubstance UI="D005277">Fenfluramine</NameOfSubstance></Chemical><Chemical><RegistryNumber>63S8C3RXGS</RegistryNumber><NameOfSubstance UI="D014308">Triparanol</NameOfSubstance></Chemical><Chemical><RegistryNumber>69U0IKR8FP</RegistryNumber><NameOfSubstance UI="D007488">Iprindole</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>NHW07912O7</RegistryNumber><NameOfSubstance UI="D002745">Chlorphentermine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000307" MajorTopicYN="N">Adrenal Gland Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000639" MajorTopicYN="N">Amitriptyline</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001067" MajorTopicYN="N">Appetite Depressants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055598" MajorTopicYN="N">Chemical Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002621" MajorTopicYN="N">Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002745" MajorTopicYN="N">Chlorphentermine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005277" MajorTopicYN="N">Fenfluramine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007488" MajorTopicYN="N">Iprindole</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008064" MajorTopicYN="N">Lipidoses</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010743" MajorTopicYN="N">Phospholipids</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013733" MajorTopicYN="N">Testicular Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013959" MajorTopicYN="N">Thyroid Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014308" MajorTopicYN="N">Triparanol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>38</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1973</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1973</Year><Month>8</Month><Day>31</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1973</Year><Month>8</Month><Day>31</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">4150413</ArticleId><ArticleId IdType="doi">10.1055/s-0028-1107096</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Lullmann Rauch, R" sort="Lullmann Rauch, R" uniqKey="Lullmann Rauch R" first="R" last="Lüllmann-Rauch">R. Lüllmann-Rauch</name><name sortKey="Lullmann, H" sort="Lullmann, H" uniqKey="Lullmann H" first="H" last="Lüllmann">H. Lüllmann</name><name sortKey="Wassermann, O" sort="Wassermann, O" uniqKey="Wassermann O" first="O" last="Wassermann">O. Wassermann</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001066 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001066 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:4150413
|texte= [Drug-induced phospholipid storage disease].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:4150413" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |